当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 现金流量表

华北制药

(600812)

  

流通市值:80.12亿  总市值:80.12亿
流通股本:17.16亿   总股本:17.16亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,631,479,997.443,144,049,246.961,436,562,723.527,527,509,548.09
  收到的税费返还104,816,709.4961,366,537.8935,986,090.2145,071,333.8
  收到其他与经营活动有关的现金168,152,967.22109,390,578.7428,853,511.67167,204,666.32
  经营活动现金流入小计4,904,449,674.153,314,806,363.591,501,402,325.397,839,785,548.21
  购买商品、接受劳务支付的现金2,123,639,655.591,412,147,764.21681,682,711.953,628,506,307.49
  支付给职工以及为职工支付的现金957,798,761.02636,246,550.09326,122,616.791,346,365,383.19
  支付的各项税费329,078,583.31248,151,278.4122,265,813.92489,651,459.12
  支付其他与经营活动有关的现金774,343,499.68467,447,630.08212,665,026.321,198,723,142.41
  经营活动现金流出小计4,184,860,499.62,763,993,222.781,342,736,168.986,663,246,292.21
  经营活动产生的现金流量净额719,589,174.55550,813,140.81158,666,156.411,176,539,256
二、投资活动产生的现金流量:
  取得投资收益收到的现金338,101.02--60,468,966.15
  处置固定资产、无形资产和其他长期资产收回的现金净额1,065,861.35111,20040,200615,026.21
  收到的其他与投资活动有关的现金94,900,80094,900,800--
  投资活动现金流入小计96,304,762.3795,012,00040,20061,083,992.36
  购建固定资产、无形资产和其他长期资产支付的现金376,558,350.41256,271,661.75122,790,203.99542,012,200.76
  投资支付的现金---300,000,000
  投资活动现金流出小计376,558,350.41256,271,661.75122,790,203.99842,012,200.76
  投资活动产生的现金流量净额-280,253,588.04-161,259,661.75-122,750,003.99-780,928,208.4
三、筹资活动产生的现金流量:
  吸收投资收到的现金---385,000,000
  其中:子公司吸收少数股东投资收到的现金---380,000,000
  取得借款收到的现金9,756,858,0007,708,358,0003,983,598,0008,777,750,000
  收到其他与筹资活动有关的现金450,000,000200,000,000-1,650,000,000
  筹资活动现金流入小计10,206,858,0007,908,358,0003,983,598,00010,812,750,000
  偿还债务支付的现金9,628,477,872.287,757,813,988.943,963,436,872.289,146,239,928.66
  分配股利、利润或偿付利息支付的现金334,444,465254,020,240.8472,482,112.84479,672,439.18
  其中:子公司支付给少数股东的股利、利润57,490,370.9647,690,370.96-66,830,370.96
  支付其他与筹资活动有关的现金685,727,464.66734,895,517.02284,667,947.641,572,101,962.13
  筹资活动现金流出小计10,648,649,801.948,746,729,746.84,320,586,932.7611,198,014,329.97
  筹资活动产生的现金流量净额-441,791,801.94-838,371,746.8-336,988,932.76-385,264,329.97
四、汇率变动对现金及现金等价物的影响-17,257,322.62-11,699,627.56-5,914,930.01477,331.53
五、现金及现金等价物净增加额-19,713,538.05-460,517,895.3-306,987,710.3510,824,049.16
  加:期初现金及现金等价物余额1,273,228,002.181,273,228,002.181,273,228,002.181,262,403,953.02
  期末现金及现金等价物余额1,253,514,464.13812,710,106.88966,240,291.831,273,228,002.18
补充资料:
  净利润-90,872,547.55-257,453,101.84
  资产减值准备--6,650,965.62--17,226,881.24
  固定资产和投资性房地产折旧-344,058,266.12-652,528,855.33
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-344,058,266.12-652,528,855.33
  无形资产摊销-142,213,418.09-241,809,700.87
  长期待摊费用摊销-8,556,374.96-14,569,081.94
  处置固定资产、无形资产和其他长期资产的损失--217,802.15--827,335.68
  固定资产报废损失----32.19
  财务费用-151,511,629.14-361,548,158.82
  投资损失--31,632,214.99--60,625,000.37
  递延所得税--2,502,710.25--5,268,853.1
  其中:递延所得税资产减少--2,502,710.25-23,283,851.89
    递延所得税负债增加----28,552,704.99
  存货的减少--54,232,202.07-118,902,218.35
  经营性应收项目的减少--157,979,127.61--197,849,078.66
  经营性应付项目的增加-45,366,572.87--283,443,368.66
  现金的期末余额-812,710,106.88-1,273,228,002.18
  减:现金的期初余额-1,273,228,002.18-1,262,403,953.02
  现金及现金等价物的净增加额--460,517,895.3-10,824,049.16
公告日期2026-10-282026-08-222026-04-252026-04-18
审计意见(境内)标准无保留意见
TOP↑